Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?

References

• Who.int. WHO Statement on COVID-19. 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020
   Google Scholar
• Satija N, Lal SK. The molecular biology of SARS coronavirus. Ann N Y Acad Sci. 2007;1102:26–18.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:P1054–1062.
   PubMed Web of Science ®Google Scholar
• Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. Epub ahead of print. DOI: 10.1056/NEJMoa2002032.
   Web of Science ®Google Scholar
• Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. 2020;395:846–848.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020. Epub ahead of print. DOI: 10.1001/jamainternmed.2020.0994.
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
   PubMed Web of Science ®Google Scholar
• Hosseiny M, Kooraki S, Gholamrezanezhad A, et al. Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and middle east respiratory syndrome. AJR Am J Roentgenol. 2020;1–5. DOI:10.2214/AJR.19.22455.
   Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Prim. 2019;5:18.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–2533.
   PubMed Web of Science ®Google Scholar
• Yao XH, Li TY, He ZC, et al. A pathological report of three COVID-19 cases by minimally invasive autopsies. Chin J Pathol. 2020;49:E009.
   Google Scholar
• Spagnolo P, Balestro E, Aliberti S, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med. 2020. Epub ahead of print. DOI: 10.1016/S2213-2600(20)30222-8.
   Web of Science ®Google Scholar
• Das KM, Lee EY, Singh R, et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging. 2017;27:342–349.
   PubMedGoogle Scholar
• Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3:24–32.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7:154–162.
   PubMed Web of Science ®Google Scholar
• Laffey JG, Matthay MA. Fifty years of research in ARDS. cell-based therapy for acute respiratory distress syndrome. Biology and potential therapeutic value. Am J Respir Crit Care Med. 2017;196:266–273.
   PubMed Web of Science ®Google Scholar
• Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;4:30087.
   PubMed Web of Science ®Google Scholar
• Ong S-G, Wu JC. Exosomes as potential alternatives to stem cell therapy in mediating cardiac regeneration1. Circ Res. 2015;7–9. DOI:10.1161/CIRCRESAHA.115.306593
   Web of Science ®Google Scholar
• Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve the outcome of a murine model of sepsis. Mol Ther. 2018;26:1375–1384.
   PubMed Web of Science ®Google Scholar
• Eppensteiner J, Davis RP, Barbas AS, et al. Immunothrombotic activity of damage-associated molecular patterns and extracellular vesicles in secondary organ failure induced by trauma and sterile insults. Front Immunol. 2018;9:190.
   PubMed Web of Science ®Google Scholar
• Gaborit BJ, Bergmann J-F, Mussini C, et al. Plea for multitargeted interventions for severe COVID-19. Lancet Infect Dis. 2020. Epub ahead of print. DOI: 10.1016/S1473-3099(20)30312-1.
   Web of Science ®Google Scholar
• Clinicaltrials.gov. A pilot clinical study on inhalation of mesenchymal stem cells exosomes treating severe novel coronavirus pneumonia. 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04276987?term=NCT04276987&draw=2&rank=1
   Google Scholar
• Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.0; updated Jul. Cochrane; 2019. Available from: www.training.cochrane.org/handbook.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341.
   PubMed Web of Science ®Google Scholar
• National Institute for Health Research. PROSPERO international prospective register of systematic reviews. 2011. Available from: https://www.crd.york.ac.uk/prospero
   Google Scholar
• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
   PubMed Web of Science ®Google Scholar
• Hooijmans CR, Rovers MM, de Vries RBM, et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.
   PubMed Web of Science ®Google Scholar
• Lewin S, Glenton C, Munthe-Kaas H, et al. Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2015;12:e1001895.
   PubMed Web of Science ®Google Scholar
• Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.
   PubMed Web of Science ®Google Scholar
• Wang J, Huang R, Xu Q, et al. Mesenchymal stem cell-derived extracellular vesicles alleviate acute lung injury via transfer of miR-27a-3p. Crit Care Med. 2020. Epub ahead of print. DOI: 10.1097/CCM.0000000000004315.
   Web of Science ®Google Scholar
• Dinh P-UC, Paudel D, Brochu H, et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat Commun. 2020;11:1064.
   PubMed Web of Science ®Google Scholar
• Gao Y, Sun J, Dong C, et al. Extracellular vesicles derived from adipose mesenchymal stem cells alleviate PM2.5-Induced lung injury and pulmonary fibrosis. Med Sci Monit. 2020;26:e922782.
   Web of Science ®Google Scholar
• Yu Q, Wang D, Wen X, et al. Adipose-derived exosomes protect the pulmonary endothelial barrier in ventilator-induced lung injury by inhibiting the TRPV4/Ca2+ signaling pathway. Am J Physiol Lung Cell Mol Physiol. 2020;318:L723–41.
   Web of Science ®Google Scholar
• Huang R, Qin C, Wang J, et al. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury. Aging (Albany NY). 2019;11:7996–8014.
   Google Scholar
• Silva JD, de Castro LL, Braga CL, et al. Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology. Stem Cells Int. 2019;2019:8262849.
   PubMed Web of Science ®Google Scholar
• Zhang C, Guo F, Chang M, et al. Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-kappaB signaling axis and glycocalyx enhancement. Exp Cell Res. 2019;384:111596.
   PubMed Web of Science ®Google Scholar
• Hao Q, Gudapati V, Monsel A, et al. Mesenchymal stem cell-derived extracellular vesicles decrease lung injury in mice. J Immunol. 2019;203:1961–1972.
   Web of Science ®Google Scholar
• Kim SY, Joglekar MV, Hardikar AA, et al. Placenta stem/stromal cell-derived extracellular vesicles for potential use in lung repair. Proteomics. 2019;19:e1800166.
   Web of Science ®Google Scholar
• Yi X, Wei X, Lv H, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. 2019;383:111454.
   PubMed Web of Science ®Google Scholar
• Chen W, Wang S, Xiang H, et al. Microvesicles derived from human Wharton’s Jelly mesenchymal stem cells ameliorate acute lung injury partly mediated by hepatocyte growth factor. Int J Biochem Cell Biol. 2019;112:114–122.
   Web of Science ®Google Scholar
• Xu N, Shao Y, Ye K, et al. Mesenchymal stem cell-derived exosomes attenuate phosgene-induced acute lung injury in rats. Inhal Toxicol. 2019;31:52–60.
   PubMed Web of Science ®Google Scholar
• Mansouri N, Willis GR, Fernandez-Gonzalez A, et al. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. JCI Insight. 2019;4:e128060.
   PubMed Web of Science ®Google Scholar
• Loy H, Kuok DIT, Hui KPY, et al. Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A(H5N1) virus-associated acute lung injury. J Infect Dis. 2019;219:186–196.
   PubMed Web of Science ®Google Scholar
• Li Q-C, Liang Y, Su Z-B. Prophylactic treatment with MSC-derived exosomes attenuates traumatic acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol. 2019;316:L1107–17.
   PubMed Web of Science ®Google Scholar
• Varkouhi AK, Jerkic M, Ormesher L, et al. Extracellular vesicles from interferon-gamma-primed human umbilical cord mesenchymal stromal cells reduce escherichia coli-induced acute lung injury in rats. Anesthesiology. 2019;130:778–790.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury. Crit Care. 2019;23:44.
   PubMed Web of Science ®Google Scholar
• Park J, Kim S, Lim H, et al. Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia. Thorax. 2019;74:43–50.
   PubMed Web of Science ®Google Scholar
• Royce SG, Patel KP, Mao W, et al. Serelaxin enhances the therapeutic effects of human amnion epithelial cell-derived exosomes in experimental models of lung disease. Br J Pharmacol. 2019;176:2195–2208.
   Web of Science ®Google Scholar
• Sun L, Zhu M, Feng W, et al. Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage. Oxid Med Cell Longev. 2019;2019:4506303.
   PubMed Web of Science ®Google Scholar
• Liu J-S, Du J, Cheng X, et al. Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury. J Chin Med Assoc. 2019;82:895–901.
   PubMed Web of Science ®Google Scholar
• Sun A, Lai Z, Zhao M, et al. Native nanodiscs from blood inhibit pulmonary fibrosis. Biomaterials. 2018;192:51–61.
   Web of Science ®Google Scholar
• Bandeira E, Oliveira H, Silva JD, et al. Therapeutic effects of adipose-tissue-derived mesenchymal stromal cells and their extracellular vesicles in experimental silicosis. Respir Res. 2018;19:104.
   PubMed Web of Science ®Google Scholar
• Tan JL, Lau SN, Leaw B, et al. Amnion epithelial cell-derived exosomes restrict lung injury and enhance endogenous lung repair. Stem Cells Transl Med. 2018;7:180–196.
   PubMed Web of Science ®Google Scholar
• Hu S, Park J, Liu A, et al. Mesenchymal stem cell microvesicles restore protein permeability across primary cultures of injured human lung microvascular endothelial cells. Stem Cells Transl Med. 2018;7:615–624.
   PubMed Web of Science ®Google Scholar
• Zhang D, Lee H, Wang X, et al. Exosome-mediated small RNA delivery: a novel therapeutic approach for inflammatory lung responses. Mol Ther. 2018;26:2119–2130.
   PubMed Web of Science ®Google Scholar
• Shah T, Qin S, Vashi M, et al. Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome. Clin Transl Med. 2018;7:19.
   Web of Science ®Google Scholar
• Wu X, Liu Z, Hu L, et al. Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR-126. Exp Cell Res. 2018;370:13–23.
   PubMed Web of Science ®Google Scholar
• Khatri M, Richardson LA, Meulia T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018;9:17.
   PubMed Web of Science ®Google Scholar
• Wang H, Zheng R, Chen Q, et al. Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF). Stem Cell Res Ther. 2017;8:211.
   Web of Science ®Google Scholar
• Morrison TJ, Jackson MV, Cunningham EK, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017;196:1275–1286.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang S, Wang Z. High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. Biomaterials. 2017;135:62–73.
   PubMed Web of Science ®Google Scholar
• Tang X-D, Shi L, Monsel A, et al. Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA. Stem Cells. 2017;35:1849–1859.
   PubMed Web of Science ®Google Scholar
• Ju Z, Ma J, Wang C, et al. Exosomes from iPSCs delivering siRNA attenuate intracellular adhesion molecule-1 expression and neutrophils adhesion in pulmonary microvascular endothelial cells. Inflammation. 2017;40:486–496.
   PubMed Web of Science ®Google Scholar
• Shentu T-P, Huang T-S, Cernelc-Kohan M, et al. Thy-1 dependent uptake of mesenchymal stem cell-derived extracellular vesicles blocks myofibroblastic differentiation. Sci Rep. 2017;7:18052.
   PubMed Web of Science ®Google Scholar
• Li L, Jin S, Zhang Y. Ischemic preconditioning potentiates the protective effect of mesenchymal stem cells on endotoxin-induced acute lung injury in mice through secretion of exosome. Int J Clin Exp Med. 2015;8:3825–3832.
   PubMed Web of Science ®Google Scholar
• Choi SJ, Kim M-H, Jeon J, et al. Active immunization with extracellular vesicles derived from staphylococcus aureus effectively protects against staphylococcal lung infections, mainly via Th1 cell-mediated immunity. PLoS One. 2015;10:e0136021.
   PubMed Web of Science ®Google Scholar
• Monsel A, Zhu Y, Gennai S, et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med. 2015;192:324–336.
   PubMed Web of Science ®Google Scholar
• Zhu Y-G, Feng X-M, Abbott J, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells. 2014;32:116–125.
   PubMed Web of Science ®Google Scholar
• Schober A, Nazari-Jahantingh M, Wei Y, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014;20:368–376.
   PubMed Web of Science ®Google Scholar
• Hu J, Zeng L, Huang J, et al. miR-126 promotes angiogenesis and attenuates inflammation after contusion spinal cord injury in rats. Brain Res. 2015;1608:191–202.
   PubMed Web of Science ®Google Scholar
• Tang S-T, Wang F, Shao M, et al. MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic condition by targeting HMGB1. Vascul Pharmacol. 2017;88:48–55.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol. 2010;184:1702–1709.
   PubMed Web of Science ®Google Scholar
• Zhou T, Chen Y-L. The functional mechanisms of miR-30b-5p in acute lung injury in children. Med Sci Monit Int Med J Exp Clin Res. 2019;25:40–51.
   Google Scholar
• Cui H, Banerjee S, Xie N, et al. MicroRNA-27a-3p is a negative regulator of lung fibrosis by targeting myofibroblast differentiation. Am J Respir Cell Mol Biol. 2016;54:843–852.
   PubMed Web of Science ®Google Scholar
• Yang S, Cui H, Xie N, et al. miR-145 regulates myofibroblast differentiation and lung fibrosis. Faseb J. 2013;27:2382–2391.
   Web of Science ®Google Scholar
• Balakrishnan I, Yang X, Brown J, et al. Genome-wide analysis of miRNA-mRNA interactions in marrow stromal cells. Stem Cells. 2014;32:662–673.
   PubMed Web of Science ®Google Scholar
• Gong M, Yu B, Wang J, et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017;8:45200–45212.
   PubMedGoogle Scholar
• Fang S, Xu C, Zhang Y, et al. Umbilical cord-derived mesenchymal stem cell-derived exosomal MicroRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-β/SMAD2 pathway during wound healing. Stem Cells Transl Med. 2016;5:1425–1439.
   PubMed Web of Science ®Google Scholar
• van Balkom BWM, Eisele AS, Pegtel DM, et al. Quantitative and qualitative analysis of small RNAs in human endothelial cells and exosomes provides insights into localized RNA processing, degradation and sorting. J Extracell Vesicles. 2015;4:26760.
   PubMed Web of Science ®Google Scholar
• Brauer R, Ge L, Schlesinger SY, et al. Syndecan-1 attenuates lung injury during influenza infection by potentiating c-met signaling to suppress epithelial apoptosis. Am J Respir Crit Care Med. 2016;194:333–344.
   Web of Science ®Google Scholar
• Mason RJ. Hepatocyte growth factor: the key to alveolar septation? Am J Respir Cell Mol Biol. 2002;26:517–520.
   PubMed Web of Science ®Google Scholar
• McCarter SD, Mei SHJ, Lai PFH, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med. 2007;175:1014–1026.
   PubMed Web of Science ®Google Scholar
• Gutbier B, Neuhauß A-K, Reppe K, et al. Prognostic and pathogenic role of angiopoietin-1 and −2 in pneumonia. Am J Respir Crit Care Med. 2018;198:220–231.
   PubMed Web of Science ®Google Scholar
• Simpson RJ, Kalra H, Mathivanan S. ExoCarta as a resource for exosomal research. J Extracell Vesicles. 2012;1:18374.
   PubMedGoogle Scholar
• Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10:e1001450.
   PubMed Web of Science ®Google Scholar
• Van Deun J, Mestdagh P, Agostinis P, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14:228–232.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. Registered trials for use of Mesenchymal stem cells for COVID-19. 2020. Available from: https://clinicaltrials.gov/ct2/results?cond=mesenchymal+stem+cells&term=covid&cntry=&state=&city=&dist=
   Google Scholar
• Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11:216–228.
   PubMed Web of Science ®Google Scholar
• Liang B, Chen J, Li T, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells. chinaXiv. DOI:10.12074/202002.00084.
   Google Scholar
• Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9:28–38.
   Web of Science ®Google Scholar
• Rohde E, Pachler K, Gimona M. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. Cytotherapy. 2019;21:581–592.
   PubMed Web of Science ®Google Scholar
• Börger V, Weiss DJ, Anderson JD, et al. ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19. Cytotherapy. 2020. Epub ahead of print. DOI: 10.1016/j.jcyt.2020.05.002.
   Web of Science ®Google Scholar
• Antounians L, Tzanetakis A, Pellerito O, et al. The regenerative potential of amniotic fluid stem cell extracellular vesicles: lessons learned by comparing different isolation techniques. Sci Rep. 2019;9:1837.
   Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function,and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
   PubMed Web of Science ®Google Scholar
• Reiner AT, Witwer KW, van Balkom BWM, et al. Concise review: developing best‐practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med. 2017;6:1730–1739.
   PubMed Web of Science ®Google Scholar
• Pachler K, Lener T, Streif D, et al. A good manufacturing practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles. Cytotherapy. 2017;19:458–472.
   PubMed Web of Science ®Google Scholar
• Gimona M, Pachler K, Laner-Plamberger S, et al. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017;18:E1190.
   Web of Science ®Google Scholar
• Witwer KW, Van Balkom BWM, Bruno S, et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 2019;8:1609206.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Harrison P, Belting M, et al. Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 educational day. J Extracell Vesicles. 2015;4:26901.
   PubMed Web of Science ®Google Scholar
• Nielsen T, Kristensen AF, Pedersen S, et al. Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation. J Extracell Vesicles. 2018;7:1454777.
   PubMed Web of Science ®Google Scholar
• Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;7:e362–3.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020. Epub ahead of print. DOI: 10.1016/j.jacc.2020.04.031.
   Web of Science ®Google Scholar
• Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847.
   PubMed Web of Science ®Google Scholar
• Kanada M, Bachmann MH, Hardy JW, et al. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci. 2015;112:E1433–42.
   PubMed Web of Science ®Google Scholar
• Denzer K, van Eijk M, Kleijmeer MJ, et al. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol. 2000;165:1259–1265.
   PubMed Web of Science ®Google Scholar
• Meyer C, Losacco J, Stickney Z, et al. Pseudotyping exosomes for enhanced protein delivery in mammalian cells. Int J Nanomedicine. 2017;12:3153–3170.
   PubMed Web of Science ®Google Scholar
• Yim N, Ryu S-W, Choi K, et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun. 2016;7:12277.
   PubMed Web of Science ®Google Scholar
• Ragni E, Banfi F, Barilani M, et al. Extracellular vesicle-shuttled mRNA in mesenchymal stem cell communication. Stem Cells. 2017;35:1093–1105.
   PubMed Web of Science ®Google Scholar
• Lai CP, Kim EY, Badr CE, et al. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat Commun. 2015;6:7029.
   PubMed Web of Science ®Google Scholar
• Grange C, Tapparo M, Bruno S, et al. Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging. Int J Mol Med. 2014;33:1055–1063.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020. Epub ahead of print. DOI: 10.1093/cvr/cvaa106.
   Web of Science ®Google Scholar
• Khan M, Nickoloff E, Abramova T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015;117:52–64.
   PubMed Web of Science ®Google Scholar
• Umscheid CA, Margolis DJ, Grossman CE. Key concepts of clinical trials: a narrative review. Postgrad Med. 2011;123:194–204.
   PubMed Web of Science ®Google Scholar
• Miller JE, Ross JS, Moch KI, et al. Characterizing expanded access and compassionate use programs for experimental drugs. BMC Res Notes. 2017;10:350.
   PubMedGoogle Scholar
• Whitfield K, Huemer K-H, Winter D, et al. Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries. Trials. 2010;11:104.
   PubMed Web of Science ®Google Scholar
• fda.gov/. U.S. Food & Drug Administration Press Release. 2020. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-accelerate-development-novel-therapies-covid-19
   Google Scholar
• Xing D, Kwong J, Yang Z, et al. Intra-articular injection of mesenchymal stem cells in treating knee osteoarthritis: a systematic review of animal studies. Osteoarthr Cartil. 2018;26:445–461.
   Web of Science ®Google Scholar